Parkinson’s Disease
Parkinson’s Disease is a disorder of the central nervous system that affects movement, often including tremors.
Nerve cell damage in the brain causes dopamine levels to drop, leading to the symptoms of Parkinson’s.
Parkinson’s often starts with a tremor in one hand. Other symptoms are slow movement, stiffness, and loss of balance.
Medications can help control the symptoms of Parkinson’s.
Parkinson’s Disease is a progressive disease of the nervous system marked by tremor, muscular rigidity, and slow, imprecise movement, chiefly affecting middle-aged and elderly people. It is associated with degeneration of the basal ganglia of the brain and a deficiency of the neurotransmitter dopamine.
Symptoms:
Cluster Number:
Wiki Number: PW153
Diagnosis: Parkinson’s Disease (Very complex; please read the Wikipedia article.)
US Patients: 2-6X likelihood of dementia
World Patients: 6.2Mil&117,400 Deaths (2015)
Sex Ratio:
Age Onset: Over 60, usually; unless “early-onset Parkinson’s”
Brain Area: Cell deaths among the subantia nigra leads to dopamine deficits; Cells die from proteins into Lewy bodies in the neurons
Symptoms: tremor, slowness(bradykinesia), stiffness(excessive muscle contraction) and postural instability(10% fall weekly)
Progression: As it progresses, poor decision-making, less impulse control, impaired recall, less control of attention
Causes: genetics, injuries, pesticides;brain lesions from strokes;alpha-synuclein protein in the brain buildup; 50% have hallucinations
Medications: L-DOPA; deep brain stimulation by microelectrodes reduces muscular symptoms;
Therapies: Imaging by MRI, T2* and SW;, neuromelanin-MRI; Diffusion, MRI; PET; SPECT; DaTSCAN is the only FDA approved way to distinguish.
Youtube Video: Parkinson’s Disease: Adversity or Adventure?
Amazon or Library Book:
Parkinson’s Disease – Guide for the Newly Diagnosed
Click the book to link or buy from Amazon.
Support Group: parkinsons.org; 800-473-4636
(Parkinson’s Disease Foundation)
Support Group:michaeljfox.org; (Primarily designed to find a cure for Parkinson’s Disease. It may also have support groups.)
Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services,
Section 12.02.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Combination therapy of phytonanomedicine and post-biotic for the management of Parkinson's diseaseby Bushra Bashir on December 3, 2024
No abstract
- SPG7 mutation - Novel phenotypic presentation mimicking idiopathic Parkinson's diseaseby Karri Madhavi on December 3, 2024
•SPG7 mutations can present as asymmetric parkinsonism mimicking idiopathic Parkinson's disease,•SPG7 mutation must be considered in Early onset Parkinson's disease even with a negative family history.•Parkinsonism with SPG7 mutations has shown good to moderate response to dopamine.
- The clinical perspective of circular RNAs in neurodegenerative diseases: potential diagnostic tools and therapeutic targetsby Xin'ai Li on December 3, 2024
Neurodegenerative diseases (NDDs) mostly occur in older demographics. With the average lifespan increasing over time, NDDs are becoming one of the major adverse factors affecting human health and the quality of life. Currently, there are no specific diagnostic methods for NDDs and they are usually diagnosed based on nonspecific clinical symptoms and occasionally by biomarkers, such as β-amyloid (Aβ) for Alzheimer's disease (AD) and a-synuclein (α-syn) for Parkinson's disease, etc. However, it is...
- Liquid antipsychotics in the management of psychomotor agitation: a focus on promazineby Marta Matrone on December 3, 2024
Psychomotor agitation (PMA) is a prominent clinical issue frequently observed in various psychiatric and neurological conditions, including schizophrenia, bipolar disorder, Parkinson disease, dementia and substance use disorder. Characterized by motor restlessness, anxiety and irritability, PMA can rapidly escalate into aggression and violence, necessitating prompt intervention to ensure patient and caregiver safety. The prevalence of PMA in psychiatric emergency settings ranges from 4.3% to...